Search

everythinglearnresearchcommunity

for

Search:↓

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

OCT can effectively screen and diagnose various medical conditions non-invasively.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The document concludes that scalp conditions have various causes and can present in many different ways.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Phototherapy can help treat hair loss in alopecia areata.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.